Compulsory licenses in the access of the vaccine of covid-19 by African countries
Introduction
By the end of 2019, humanity was confronted by a new infectious disease caused by a new coronavirus, the covid-19 that led, on March 11th, 2020 the Word Health Organization (WHO) to declare the state of a global pandemic.
Vítor Palmela Fidalgo from Inventa International, publishes an article in the prestigious german magazine GRUR Int.
Vítor Palmela Fidalgo, Director of the Intellectual Property department at Inventa International, publishes an article in the prestigious german magazine Gewerblicher Rechtsschutz und Urheberrecht, Internationaler Teil (GRUR Int), entitled “Challenges in Protecting Pharmaceutical Trademarks”, where some of the main juridical questions that come up with trademark protection which designate pharmaceutical products are addressed.
Link: https://goo.gl/9BJzNU
World Health Assembly: Is a compulsory licensing a solution against the high price of medicines?
The Sixty-eighth session of the World Health Assembly (WHA) took place in Geneva 18–26 May 2015. One of the issues that have been addressed was the high prices of medicines in Europe. Actually this is a growing problem in the EU. In the past few years the price of the medicines have been increasing exceeding the ability of the patients to pay for it. It is enough to recall the recent case involving the drugs to treat hepatitis C (HCV) which have an unsustainable price when compared to previous generation treatments.